Masimo Corp Shares Approach 52-Week Low - Market Mover
The shares closed 0.3% above its 52-week low of $198.90, with trading volume higher than its 30 day average
Jan 28, 2022 by Kwhen Finance Editors
Masimo Corp (MASI) shares closed today at 0.3% above its 52 week low of $198.90, giving the company a market cap of $11B. The stock is currently down 31.9% year-to-date, down 20.5% over the past 12 months, and up 174.9% over the past five years. This week, the Dow Jones Industrial Average fell 1.6%, and the S&P 500 fell 3.5%.
Trading Activity
- Trading volume this week was 80.0% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Fundamentals & Catalysts
- Over the past 12 months the company generated $283 million in earnings before interest and taxes from $1 billion in revenue. It currently holds $551 million in cash and $196 million in debt.
- Its forward price-to-earnings (P/E) ratio of 57.11258133862776 is higher than its current P/E ratio of 47.47, implying that analysts are expecting a decrease in earnings.
- The company's price/earnings-to-growth ratio (PEG Ratio), a widely used indicator of a stock's true value while also factoring in expected earnings growth, currently stands at 7.46. A fairly valued company should have a PEG ratio of 1.0. When a company's PEG exceeds 1.0, it's considered overvalued while a stock with a PEG of less than 1.0 is considered undervalued.
- The company's debt-to-equity ratio, which measures the extent to which it finances its operations through debt, currently stands at 1.20 which means it currently has $1.20 of debt for every $1 of equity. Generally speaking, a debt to equity ratio below 1.0 is seen as relatively safe, while ratios of 2.0 or higher would be considered risky. Some industries are known for having much higher debt to equity ratios than others.
- The company's price-to-book ratio, which measures the market's valuation of a company relative to its book value, currently stands at 8.93. This means that the stock is trading at a premium of 9 times relative to the company's book value which reflects the total value of a company's assets that shareholders of that company would receive if the company were to be liquidated.
- The company's price-to-sales ratio, which shows how much the market values every dollar of the company's sales, currently stands at 10.11.
- The company's enterprise value-to-revenue multiple, which is often used to determine a company's valuation in the case of a potential acquisition, currently stands at 9.64.
P/E
47.47
EBITDA
$283M
P/Book
8.93
Mkt Cap
$11B
P/Sales
10.11
Revenue
$1B
EPS (TTM)
4.02
PEG Ratio
7.46
EV/Revenue
9.64
Total Cash
$551M
Debt/Equity
1.20
Forward P/E
57.11
Current Debt
$196M
Gross Profit
$754M
Dividend Date
-
Earnings Date
2022-02-15
Profit Margin
0.20
Revenue/Share
21.33
Total Revenue
$1B
Enterprise Val
$11B
Put/Call Ratio
0.63
Revenue/Employee
221351.32
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis
Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|
Masimo Corp | -2.9 | -31.9 | -20.5 | ||
Dow Jones Industrial Average | 0.0 | -5.9 | 14.6 | -6.7 | 17.3 |
S&P 500 Index | -0.5 | -9.2 | 16.7 | -8.7 | 20.6 |
Health Care | -0.1 | -10.8 | 8.6 | -11.1 | 14.2 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 232.9%
- The company's stock price performance over the past 12 months lags the peer average by -294.9%
- The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -1513.6% higher than the average peer.
Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|---|
Masimo Corp | MASI | 47.5 | -31.9 | -20.5 | ||
Peer Avg | N/A | -3.4 | -9.6 | 10.5 | -20.1 | 21.7 |
Thermo Fisher Scientific Inc. | TMO | 25.5 | -17.0 | 15.0 | -15.4 | 31.4 |
General Electric Co. | GE | -235.8 | -5.5 | -0.8 | -22.5 | 6.1 |
Resmed Inc. | RMD | 65.6 | -13.7 | 5.8 | -24.9 | 26.6 |
Koninklijke Philips N.V. - ADR | PHG | 19.5 | -12.7 | -42.0 | -46.4 | 2.9 |
Cardinal Health, Inc. | CAH | 12.6 | -1.3 | -5.1 | -15.7 | 12.7 |
UFP Industries Inc | UFPI | 10.9 | -14.7 | 41.3 | ||
Conmed Corp. | CNMD | 61.1 | -8.3 | 13.8 | -20.3 | 17.4 |
Owens & Minor, Inc. | OMI | 13.8 | -3.5 | 56.2 | -15.5 | 76.2 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: